Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01471197
What this trial is testing

Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer - Non Small Cell
Bristol-Myers Squibb 9
Testing effectiveness (Phase 2)UnknownNCT04755868
What this trial is testing

Talazoparib Maintenance Therapy in Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Yonsei University 206
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07432568
What this trial is testing

Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07512674
What this trial is testing

Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer

Who this might be right for
Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis
Sir Run Run Shaw Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT06261359
What this trial is testing

CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Qilu Pharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT00727207
What this trial is testing

Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy

Who this might be right for
Lymphoma
Technical University of Munich 35
Early research (Phase 1)Study completedNCT05155709
What this trial is testing

Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 14
Early research (Phase 1)Study completedNCT00485277
What this trial is testing

A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Bavarian Nordic 9
Large-scale testing (Phase 3)Study completedNCT00003998
What this trial is testing

Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
University of Glasgow 1,050
Testing effectiveness (Phase 2)Study completedNCT00531934
What this trial is testing

Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer.

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 147
Large-scale testing (Phase 3)UnknownNCT02024412
What this trial is testing

Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC

Who this might be right for
Colorectal Cancer
Tianjin Medical University Cancer Institute and Hospital 240
Testing effectiveness (Phase 2)Study completedNCT02883556
What this trial is testing

Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

Who this might be right for
Carcinoma, Squamous Cell
Assistance Publique - Hôpitaux de Paris 57
Testing effectiveness (Phase 2)Ended earlyNCT00356681
What this trial is testing

AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

Who this might be right for
Breast NeoplasmsBreast TumorsBreast Cancer+1 more
Amgen 282
Early research (Phase 1)UnknownNCT05001412
What this trial is testing

Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Zhou Chengzhi 36
Large-scale testing (Phase 3)Ended earlyNCT01319669
What this trial is testing

Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Chinese Society of Lung Cancer 11
Testing effectiveness (Phase 2)Looking for participantsNCT07514494
What this trial is testing

Intensification Treatment of Ovarian Cancer by PIPAC

Who this might be right for
Advanced Epithelial Ovarian CancerPeritoneal Carcinomatosis
Moscow Regional Oncological Dispensary 160
Large-scale testing (Phase 3)UnknownNCT04146402
What this trial is testing

SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sinocelltech Ltd. 330
Large-scale testing (Phase 3)Active Not RecruitingNCT05224141
What this trial is testing

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

Who this might be right for
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC 460
Testing effectiveness (Phase 2)Study completedNCT03425201
What this trial is testing

Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA)

Who this might be right for
Urothelial Cancer
Fundacion CRIS de Investigación para Vencer el Cáncer 67
Large-scale testing (Phase 3)Study completedNCT03607539
What this trial is testing

Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC

Who this might be right for
Lung Neoplasms
Innovent Biologics (Suzhou) Co. Ltd. 397
Next Page